Discovery
CD19 CAR-T resets refractory SLE
CD19 CAR-T induced drug-free remission in refractory SLE in early case series.
In short
- 1What it is: a discovery in research intelligence.
- 2How it connects: acts on 3 and is affected by 0 concepts — mostly 1 disease, 2 therapy.
- 3Where it sits: discovery on the 15-step immune chain.
Its connections at a glance
Each dot is a concept directly linked to CD19 CAR-T resets refractory SLE. Colours show the kind of concept.
Sources & evidenceloading…
Loading reviewed sources…
Graph ID DS004 · concept status: emerging. Select any connection above to inspect evidence for that specific link.